Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03572400 |
|---|---|
| Brief Title: | Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer |
| First Submitted : | June 18, 2018 |
| First Submitted that Met QC Criteria : | June 26, 2018 |
| First Posted : | June 28, 2018 |
| Last Update Submitted that Met QC Criteria : | March 15, 2021 |
| Last Update Posted : | March 17, 2021 |